TGFB1 and carcinoma: First, elevated secretion of TGF-β is commonly observed in lots of malignancies, including both cancerous and stromal cells, such as carcinoma-associated fibroblasts (CAFs), vascular endothelial cells (VECs), and mesenchymal stem cells (MSCs) [31–33].